Food Frequency Questionnaire (FFQ) for Coronary Heart Disease (CHD) Patients
Evaluation of the Psychometric Properties of a Food Frequency Questionnaire Developed for Patients With Coronary Heart Disease in Northern China
1 other identifier
observational
235
1 country
2
Brief Summary
This study aims to evaluate the psychometric properties of a newly developed FFQ specified for northern Chinese CHD and their high risk patients (CHD-FFQ). The psychometric properties include test-retest reliability, content validity, convergent validity, discriminant validity, concurrent validity and predictive validity. Particularly, this study will measure the physiological indicators, including plasma lipid profile (i.e. TG, TC, HDL-C, LDL-C), BG, BP and BMI twice at baseline and the end. The level of these physiological indicators will be compared with the fat intake measured by the CHD-FFQ, i.e. the baseline intake to test its convergent validity. It is also expected to predict the diet-related progression of CHD risks among high-risk individuals, i.e. patients with two or more CHD risk factors as following: raised fasting blood glucose (BG) level, increased blood pressure (BP), increased triglycerides (TG), decreased HDL-Cholesterol (HDL-C), increased LDL-Cholesterol (LDL-C), smoking and central obesity (International Diabetes Federation, 2015). In addition, this study will provide the FFQ's concurrent validity in assessing the intake of energy and nutrients against the CDC-FFQ. Moreover, whether the FFQ could detect the known differences in energy intake between men and women will be established for its discriminant validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2017
CompletedFirst Submitted
Initial submission to the registry
September 19, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2017
CompletedJanuary 25, 2018
January 1, 2018
11 months
September 19, 2017
January 23, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Intake of Food
The newly developed FFQ (CHD-FFQ) will be applied to the participants to collect their dietary intake of food.
January-February, April- May, July- August, October- November
Cardiac-related physiological blood parameters
In the beginning and the end of the study, the medical records of the participants will be refered to get the blood glucose, total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in the past three months, in the department and the community centers.
January- February, October- November
Height
Participant's height will be measured to the nearest 0.5 cm, with a right-angle triangle resting on the scalp and against the wall, having the back square against the wall tape and eyes looking straight ahead. The height will be measured without wearing shoes.
January-February, April- May, July- August, October- November
Weight
A calibrated scale with the resolution of 0.1 kg will be used to measure the weight of the participants, who will be asked to wear light clothes during measurement. The weight will be measured without shoes.
January-February, April- May, July- August, October- November
BMI
weight and height will be combined to report BMI in kg/m\^2
January-February, April- May, July- August, October- November
Waist circumstance
Waist circumstance will be taken at the midpoint between the top of the iliac crest and the lower margin of the palpable rib
January-February, April- May, July- August, October- November
Blood pressure
To take the blood pressure, the participant will be asked to be seated for at least 15 minutes with his/her legs uncrossed (WHO, 2008). Two BP measurements will be taken and between the two readings, the participant will have three minutes' rest.
January-February, April- May, July- August, October- November
Intake of Food
As a criterion, the FFQ developed by Chinese CDC will be applied to the participants to collect their dietary intake of food.
October-November
Secondary Outcomes (4)
Sociodemographic information
January-February
General clinical information
January-February
Clinical Information
October- November
Physical activity level
January-February, April- May, July- August, October- November
Eligibility Criteria
CHD high-risk patients (corresponding to the inclusion criteria)
You may qualify if:
- years or older;
- Have no CHD at enrollment;
- At high risk of CHD with at least two of the following risk factors:
- current smoking: current smokers are defined as individuals who smoked regularly during the last 12 months
- central obesity: for Chinese, central obesity is defined as waist circumstance above 90cm for male and 80cm for female, or with BMI above 30kg/m²
- raised BP (systolic BP \[SBP\] ≥ 130 mmHg or diastolic BP \[DBP\] ≥85 mmHg or under antihypertensive treatment)
- raised fasting BG (FBG) (100mg/dL \[5.6mmol/L\]) or under treatment with insulin or oral hypoglycemic agents
- elevated TG (150mg/dL \[1.7mmol/L\])
- elevated TC (≥ 240 mg/dL \[5.18 mmol/L\])
- raised LDL-C (≥ 160 mg/dL \[4.15 mmol/L\])
- decreased HDL-C (\<40 mg/dL \[1.03 mmol/L\] for males, and \<50 mg/dL \[1.29 mmol/L\] for females)
- undergoing hyperlipidemia treatment
You may not qualify if:
- Impaired bilateral hearing
- Impaired mental status (according to their medical record)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Qilu Hospital
Jinan, Shandong, 250012, China
Jinan Central Hospital
Jinan, Shandong, 250013, China
Biospecimen
Blood testing for the blood glucose, lipid profile
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SekYing CHAIR, PHD
Chinese University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate Assistant
Study Record Dates
First Submitted
September 19, 2017
First Posted
September 25, 2017
Study Start
January 13, 2017
Primary Completion
December 15, 2017
Study Completion
December 15, 2017
Last Updated
January 25, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share
All questionnaires and other collected data will be stored in a locked file cabinet, and no names or other personal data of participants will be used in publication. Only the PI and her supervisor will have access to these data.